1. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors;Takahashi;Cell,2006
2. RIKEN suspends first clinical trial involving induced pluripotent stem cells;Garber;Nat Biotech,2015
3. WHO. WHO good manufacturing practices for pharmaceutical products: main principles—2014. Available at: http://www.who.int/medicines/areas/quality_safety/quality_assurance/TRS986annex2.pdf?ua=1. Accessed June 25, 2016.
4. WHO. Handbook for good laboratory practise (GLP)—2009. Available at: http://www.who.int/tdr/publications/documents/glp-handbook.pdf. Accessed June 25, 2016.
5. FDA. Guidance for industry: regulation of human cells, tissues, and cellular and tissue-based products (HCT/Ps)— small entity compliance guide—2007. Available at: http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Tissue/ucm073366.htm. Accessed June 25, 2016.